Bio-Techne (TECH) Receivables - Other (2010 - 2016)
Bio-Techne's quarterly Receivables - Other came in at $1.1 million in Q1 2016, up 13.06% year-on-year from $942000.0 in Q2 2015, and down 10.88% quarter-over-quarter from $1.2 million in Q4 2015.
Bio-Techne has reported Receivables - Other for 7 years, with the latest figure at $1.1 million in Q1 2016.
- For the quarter ending Q1 2016, Receivables - Other rose 13.06% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2016 stood at $1.1 million (up 13.06% YoY), and the FY2015 full-year result was $954000.0, down 86.61% from the prior year.
- Receivables - Other for Q1 2016 stood at $1.1 million, down from $1.2 million in the prior quarter.
- The five-year high for Receivables - Other was $7.1 million in Q2 2014, with the low at $668000.0 in Q3 2014.
- Average Receivables - Other over 5 years is $1.9 million, with a median of $1.8 million recorded in 2012.
- Year-over-year, Receivables - Other jumped 257.78% in 2014 and sank 86.61% in 2015.
- Tracing TECH's Receivables - Other over 5 years: stood at $2.1 million in 2012, then declined by 0.42% to $2.1 million in 2013, then sank by 44.9% to $1.2 million in 2014, then advanced by 1.88% to $1.2 million in 2015, then slipped by 10.88% to $1.1 million in 2016.
- The last three Receivables - Other figures came in at $1.1 million (Q1 2016), $1.2 million (Q4 2015), and $972000.0 (Q3 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 1.07 Mn |
| Mar 31, 2016 | 1.07 Mn |
| Dec 31, 2015 | 1.20 Mn |
| Dec 31, 2015 | 1.20 Mn |
| Sep 30, 2015 | 972,000.00 |
| Sep 30, 2015 | 972,000.00 |
| Jun 30, 2015 | 954,000.00 |
| Jun 30, 2015 | 954,000.00 |
| Mar 31, 2015 | 942,000.00 |
| Mar 31, 2015 | 942,000.00 |
| Dec 31, 2014 | 1.17 Mn |
| Dec 31, 2014 | 1.17 Mn |
| Sep 30, 2014 | 668,000.00 |
| Sep 30, 2014 | 668,000.00 |
| Jun 30, 2014 | 7.13 Mn |
| Jun 30, 2014 | 7.13 Mn |
| Mar 31, 2014 | 1.96 Mn |
| Mar 31, 2014 | 1.96 Mn |
| Dec 31, 2013 | 2.13 Mn |
| Dec 31, 2013 | 2.13 Mn |
| Sep 30, 2013 | 1.93 Mn |
| Sep 30, 2013 | 1.93 Mn |
| Jun 30, 2013 | 1.99 Mn |
| Jun 30, 2013 | 1.99 Mn |
| Mar 31, 2013 | 1.74 Mn |
| Mar 31, 2013 | 1.74 Mn |
| Dec 31, 2012 | 2.14 Mn |
| Dec 31, 2012 | 2.14 Mn |
| Sep 30, 2012 | 1.79 Mn |
| Sep 30, 2012 | 1.79 Mn |
| Jun 30, 2012 | 2.07 Mn |
| Jun 30, 2012 | 2.07 Mn |
| Mar 31, 2012 | 1.81 Mn |
| Mar 31, 2012 | 1.81 Mn |
| Dec 31, 2011 | 2.19 Mn |
| Dec 31, 2011 | 2.19 Mn |
| Sep 30, 2011 | 1.55 Mn |
| Sep 30, 2011 | 1.55 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Mar 31, 2011 | 1.96 Mn |
| Mar 31, 2011 | 1.96 Mn |
| Dec 31, 2010 | 1.99 Mn |
| Dec 31, 2010 | 1.99 Mn |
| Sep 30, 2010 | 1.59 Mn |
| Sep 30, 2010 | 1.59 Mn |
| Jun 30, 2010 | 1.53 Mn |
| Jun 30, 2010 | 1.53 Mn |